• Needham PROSE Clinic
  • Find a PROSE Clinic
  • Donate
  • Contact Us
  • Patient Care
    • PROSE Treatment
    • Find a PROSE Clinic
    • Conditions We Treat
    • Patient Stories
    • Patient Resources
    • Pediatrics
  • Technology
    • Our Products
    • Software Platforms
    • Manufacturing
  • Education
    • Visiting Clinicians
    • FitAcademy International
    • FitAcademy for Residents
    • FitAcademy Immersive
    • Ophthalmology Resident Lectures
  • Research
    • Clinical Trials and R&D Services
    • Research Studies
    • Publications
  • About
    • Our Approach
    • News
    • Our People
    • Our Partners
  • Needham PROSE Clinic
  • Find a PROSE Clinic
  • Donate
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

Tag Archive for: PROSE

PROSE Patient, Alyssa Carfi, is Inspired to Support Others Through the Brave Minds Project

January 29, 2021/0 Comments/in Blog Posts, Patient Stories, PROSE/by michele

Alyssa Carfi had a brainstem cavernoma, a condition where blood vessels are clustered together, and in her case, lodged deep in her brainstem. The condition caused bleeding in her brainstem three times: when she was 12, 15, and 18 years old.  On the third occurrence, her doctors knew they had to try to remove it before it caused further damage.  Just three days after graduating high school, Alyssa went in for surgery.

Alyssa, standing, with Dr. Michelle Lee, and a PROSE patient who received financial support from Brave Minds.

Based on their location, brainstem cavernomas can cause significant surgical challenges. Alyssa’s cavernoma bled near her 6th and 7th cranial nerves, which affected her right eye and smile. Following her surgery, Alyssa’s right eye rotated in toward her nose, and she had facial paralysis, affecting her eyelid and ability to open and close her right eye. She underwent strabismus surgery to center her eye, and had weights put into her upper lid to help with the closure, but she was still unable to blink, leaving her right eyelid permanently open, day and night. This left her eye exposed to debris, sun, and wind, causing irritation and dryness, and risk of ongoing damage and pain.

For two years, Alyssa used eye drops and serums constantly. She would go through a large box of drops in days. She and her family saw more than 10 doctors at various hospitals and in various states, looking for a better way to live. She had Botox, then her tear ducts plugged, both with the intent to help close her eyelid. Neither worked. One doctor told her to tape her eye shut with gauze and tape.

“An 18-year-old girl doesn’t want to tape one of her eyes shut,” Alyssa says.  “And it wasn’t a good long-term solution.”

Her father had been inquiring if a non-prescription contact lens existed that she could wear.  But, because Alyssa couldn’t create her own tears in her eye, a soft contact lens would dry out almost immediately. A soft contact also didn’t cover enough of the eye surface to provide the needed protection. It was not an option.

Eventually, after a visit to a pediatric ophthalmologist at NYU’s Langone Health, they were referred to Weill Cornell Medical Center and Dr. Michelle Lee, a BostonSight PROSE™ Fellow and ocular health specialist.

Over a treatment period of six months, Alyssa and Dr. Lee worked on fitting a PROSE device. A PROSE device is a rigid, gas-permeable specialty lens that rests on the sclera of the eye (the white part) and vaults over the cornea. The vaulted reservoir is filled with a preservative-free saline solution, which continually bathes the eye in a tear-like environment to promote comfort, healing, and long-term ocular health.  Because of their strong material construction, PROSE devices protect the surface of the eye. They are also highly customizable across eight sections of the lens, are available in a range of sizes, and can include special features such as “channels” grooved into the device to avoid any eye bumps or abnormalities.  PROSE devices can also correct near or farsightedness, if needed.

“Every doctor should know about PROSE, from plastic surgeons to eye doctors. My neurosurgeon saved my life, but my plastic surgeons and eye doctors gave my life back. Living with dry eye and not being able to close my eye, no one wants to live like that. My quality of life is so much better. I don’t know how I lived life before PROSE.”

Now a PROSE patient expert after eight years with a device, Alyssa decided she wanted to share her knowledge and support. Approaching her 10-year brainstem surgery anniversary, she realized “how lucky I was. I went to college, studied abroad, have a job in public relations, and I live independently. I know that’s not the case for everyone. I really wanted to take everything my family and I went through to help other people who are experiencing the same thing.”

She launched the Brave Minds Project, a 501(c)(3) nonprofit that supports teen and young adults living with brain and brainstem conditions. The organization aims to help patients and their families from diagnosis through recovery by offering financial support for therapies and off-setting medical costs such as PROSE, providing community connection, and delivering goods that are sent to patients in the hospital and to their siblings.

PROSE treatment gave back to Alyssa the life she wanted – to live like any other young adult her age.

“PROSE is an expensive treatment and it’s not always covered by insurance.  But without it, I may have suffered severe dry eye and would have no choice but to get my eye sewn shut. For me, it’s worth it.”

Brave Minds’ goal is to help at least one person per month, regardless of financial status. Last year, Brave Minds paid for an 18-year-old student’s PROSE device.

“I was 15 when my cavernoma was officially diagnosed, and 18 when I had brainstem surgery,” says Alyssa. “This is such a critical time in your life. Your hormones are changing, you’re trying to fit in and discover who you are, and then you learn something is wrong with your brain. It’s a lot to manage and there aren’t many resources for patients this age.”

Braved Minds is based out of New Jersey and supports patients across the country.

To learn more about Alyssa and how you can support the Brave Minds Project go to www.bravemindsproject.org.

Donations to BostonSight for PROSE treatment, which is provided to those in financial need, may be made at www.bostonsight.org/donate.

https://www.bostonsight.org/wp-content/uploads/2026/06/Dr.-lee-and-Alyssa-with-Patient.jpg 1350 1080 michele /wp-content/uploads/2026/05/bostonsight-logo.svg michele2021-01-29 17:56:502026-08-03 15:55:55PROSE Patient, Alyssa Carfi, is Inspired to Support Others Through the Brave Minds Project

BostonSight Grows PROSE™ Provider Network

September 15, 2020/0 Comments/in Press Release/by michele
Expanding Access to Life Changing Eye Care That Restores Vision in People with Corneal Disease Needham, Mass. –September 15, 2020 – BostonSight®, a nonprofit eye healthcare organization and research center dedicated to saving sight and improving quality of life for patients, announced today they have added three PROSE™ Provider sites and four PROSE Clinical Fellows to the BostonSight PROSE Network. With this addition, the BostonSight PROSE Provider Network now includes 18 sites in four countries. BostonSight PROSE is a custom medical treatment model that saves sight in individuals with ocular surface disease. During treatment, doctors customize prosthetic devices from gas-permeable polymers for each patient’s condition and unique eye shape. For many people, PROSE treatment is their only option to restore visual function and end suffering from critical and devastating eye issues resulting from complications with dry eye, keratoconus, ocular GVHD, Sjögren’s Syndrome, Stevens Johnson Syndrome, corneal damage or injury, and other corneal diseases. PROSE treatment teams include cornea specialist ophthalmologists and optometrists who have completed an intensive BostonSight PROSE Clinical Fellowship. “Our mission at BostonSight is to expand our network of PROSE providers, elevate the standard of patient care, and improve quality of life for those who are suffering from corneal irregularities or ocular surface disease,” said Sara Yost, BostonSight President and CEO. “We are excited to welcome our newest PROSE Network Clinics and Fellows to provide broader access to this life-changing treatment. The new Fellows are highly regarded and experienced in the treatment of ocular surface disease and will continue to provide the expert level of care for which PROSE treatment has been recognized.” Among the additions, the BostonSight PROSE Network now includes:
  • Lee Guo. Dr. Guo joins the previously established PROSE site at the Johns Hopkins Wilmer Eye Institute in Baltimore, MD.  He is currently an assistant professor within the department of Cornea, Cataract, and External Diseases. Dr. Guo is also among clinical faculty in the multidisciplinary Johns Hopkins Sjögren’s Center and the Wilmer Ocular Surface Diseases and Dry Eye Team. He received his Doctor of Optometry degree from Nova Southeastern University and completed ocular disease residency at C.W. Bill Young VAMC in Bay Pines, FL. Dr. Guo currently assists as research investigator to various active dry eye studies and provides patient care at Wilmer Eye Institute locations in the Johns Hopkins Hospital and Bayview Medical Center in Baltimore. https://www.hopkinsmedicine.org/profiles/results/directory/profile/10004625/lee-guo
  • Robert Davis and Davis EyeCare in Chicago, IL. Dr. Davis is the medical director at the Contact Lens Clinic at Davis EyeCare. He is also co-founder of EyeVis, Eye and Vision Research Institute, developing novel contact lens designs as well as forging the knowledge of anterior segment pathophysiology. Dr. Davis has been recognized as a Diplomate in the Corneal, Contact Lens and Refractive Technology section of the American Academy of Optometry as well as an inductee in National Academy Practice in Optometry. He is an adjunct faculty member at Southern California College of Optometry – Marshall B. Ketchum University, Illinois College of Optometry, Pennsylvania College of Optometry at Salus University, and Pacific University. He has held leadership roles in the American Optometric Association, American Academy of Optometry, National Academy of Practice, and other professional organizations. https://daviseyecare.com/
  • John D. Gelles and the Cornea and Laser Eye Institute (CLEI) Center for Keratoconus in Teaneck, NJ. Dr. Gelles is a graduate of the Pennsylvania College of Optometry and is a Clinical Assistant Professor at Rutgers New Jersey Medical School Department of Ophthalmology and Visual Science. He an adjunct clinical professor at State University of New York College of Optometry, Illinois College of Optometry and New England College of Optometry. Dr. Gelles is clinical investigator for various keratoconus and specialty contact lens clinical trials and is active nationally with a number of professional organizations related to keratoconus and contact lens. Dr. Gelles is committed to helping individuals affected by complex corneal and ocular surface diseases through the utilization of advanced contact lenses, treatments, therapies, and the latest technologies to improve quality of life. With a team of specialized ophthalmologists, Dr. Peter S. Hersh, Dr. Steven A. Greenstein, and Dr. David S. Chu, CLEI provides comprehensive corneal and ocular surface disease care. https://www.vision-institute.com/
A full list of PROSE Network Sites can be found on the BostonSight website at www.bostonsight.org. About BostonSight®   BostonSight has saved the sight of thousands of individuals suffering from ocular surface disease, corneal disease, injury, or damage with BostonSight PROSE™ treatment. Founded in 1992, the Needham, MA Center of Excellence includes a clinic, research center, state-of-the-art FDA-certified and ISO-compliant manufacturing lab, and patient and family support center.  BostonSight SCLERAL was launched in 2017 to expand access to global scleral lens technology.  Eye care practitioners achieve a fast, effective scleral lens fit that provides optimal vision and comfort for patients while attaining long-term eye health. SCLERALIG is the newest innovation in BostonSight’s portfolio, using image topography to map the eye for a truly custom scleral lens fit. BostonSight envisions a world where no one suffers loss of sight from corneal irregularities or ocular surface disease. Learn more at www.bostonsight.org. Contact: Michele Hart BostonSight (617) 669-4225 mhart@bostonsight.org
https://www.bostonsight.org/wp-content/uploads/2026/06/BostonSight_PROSE_Logo_2020_RGB.jpg 767 1759 michele /wp-content/uploads/2026/05/bostonsight-logo.svg michele2020-09-15 12:00:482020-09-15 12:00:48BostonSight Grows PROSE™ Provider Network

Pages

  • About
  • Clinical Trials and R&D Services
  • Conditions We Treat
  • Contact Us
  • Dry Eye
  • Education
  • Find a PROSE Clinic
  • FitAcademy
  • FitAcademy for Residents
  • FitAcademy Immersive
  • FitAcademy International
  • GVHD
  • Home
  • Keratoconus
  • Manufacturing
  • Needham PROSE Clinic
  • News
  • Notice of Privacy Practices for Patients
  • Ophthalmology Resident Lectures
  • Our Approach
  • Our Partners
  • Our People
  • Our Products
  • Patient Care
  • Patient Information Booklet
  • Patient Resources
  • Patient Stories
  • Pediatrics
  • Post-Corneal Transplant
  • Post-LASIK
  • Practitioner IFU
  • Privacy Policy
  • PROSE Provider Payment Form
  • PROSE Treatment
  • Publications
  • Research
  • Research Studies
  • Sjögren’s Disease
  • Software Platforms
  • Stevens-Johnson Syndrome
  • Technology
  • Terms of Use
  • Visiting Clinicians
  • Ways to Support Us

Categories

  • Blog Posts
  • Clinic Updates
  • In the Media
  • Patient Stories
  • Press Release
  • PROSE
  • SCLERAL
  • Uncategorized

Archive

  • August 2026
  • July 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • January 2025
  • November 2024
  • October 2024
  • September 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • May 2023
  • March 2023
  • February 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • July 2020
  • June 2020
  • March 2020
  • Patient Care
    • PROSE Treatment
    • Find a PROSE Clinic
    • Conditions We Treat
    • Patient Stories
    • Patient Resources
    • Pediatrics
  • Technology
    • Our Products
    • Software Platforms
    • Manufacturing Lab
  • Education
    • Visiting Clinicians
    • FitAcademy International
    • FitAcademy for Residents
    • FitAcademy Immersive
    • Ophthalmology Resident Lectures
  • Research
    • Clinical Trials and R&D Services
    • Research Studies
    • Publications
  • About
    • Our Approach
    • News
    • Our People
    • Partners
  • Needham PROSE Clinic
  • Donate
  • Contact Us

BostonSight is a proud member of the Contact Lens Manufacturers Association and Supporter of the GP Lens Institute.

© 2026 BostonSight. All rights reserved.

Privacy PolicyTerms of Use

Scroll to top Scroll to top Scroll to top
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings ACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non Necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

Save & Accept